BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8087269)

  • 1. Quinapril therapy in patients with chronic mitral regurgitation.
    Schön HR; Schröter G; Barthel P; Schömig A
    J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
    Schön HR; Dorn R; Barthel P; Schömig A
    J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation.
    Schön HR; Schröter G; Blömer H; Schömig A
    Am J Cardiol; 1994 Apr; 73(11):785-91. PubMed ID: 8160617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment with quinapril in chronic aortic and mitral insufficiency].
    Schön HR; Schömig A
    Dtsch Med Wochenschr; 1995 Mar; 120(13):429-35. PubMed ID: 7712932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
    Pisacane C; Pacileo G; Santoro G; Sarubbi B; Iacono C; Russo MG; Calabrò R
    Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recovery of left ventricular function after mitral valve replacement for chronic mitral regurgitation: optimal timing of operation according to long-term recovery].
    Ishitoya H
    J Cardiol; 2000 Jul; 36(1):37-44. PubMed ID: 10929264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy.
    Didangelos TP; Arsos GA; Karamitsos DT; Athyros VG; Georga SD; Karatzas ND
    J Diabetes Complications; 2006; 20(1):1-7. PubMed ID: 16389160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.
    Harris KM; Aeppli DM; Carey CF
    Am Heart J; 2005 Nov; 150(5):1106. PubMed ID: 16291006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature.
    Knirsch W; Tlach L; Stambach D; Bauersfeld U
    Congenit Heart Dis; 2010; 5(3):278-84. PubMed ID: 20576047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation.
    Calabrò R; Pisacane C; Pacileo G; Russo MG
    Am Heart J; 1999 Nov; 138(5 Pt 1):955-61. PubMed ID: 10539829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting.
    Mallidi HR; Pelletier MP; Lamb J; Desai N; Sever J; Christakis GT; Cohen G; Goldman BS; Fremes SE
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):636-44. PubMed ID: 15001891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G; Serafini O; Caporale R; Guzzo D; Plastina F
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mitral regurgitation and chronic heart failure.
    Ennezat PV; Marechaux S; Asseman P; Lejemtel TH; Van Belle E; Bauters C; De Groote P
    Minerva Cardioangiol; 2006 Dec; 54(6):725-33. PubMed ID: 17167384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of chronic valvular regurgitation.
    Schön HR
    J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S170-4. PubMed ID: 8563994
    [No Abstract]   [Full Text] [Related]  

  • 19. Restrictive mitral valve annuloplasty for chronic ischemic mitral regurgitation: a 5-year clinical experience with the physio ring.
    Geidel S; Lass M; Ostermeyer J
    Heart Surg Forum; 2008; 11(4):E225-30. PubMed ID: 18782701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
    Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.